[시장보고서]세계의 바이오의약품 및 생물의약품 시장 : 제품 유형별, 용도별, 치료 분야별, 국가별, 지역별

세계의 바이오의약품 및 생물의약품 시장 : 제품 유형별, 용도별, 치료 분야별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 및 예측(2024-2032년)

Biopharmaceutical and Biomedicine Market, By Product Type, By Application, By Therapeutic Area, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

상품코드 : 1477166

리서치사 : AnalystView Market Insights

발행일 : 2024년 05월

페이지 정보 : 영문 300 Pages

라이선스 & 가격 (부가세 별도)

US $ 3,250

￦ 4,452,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650

￦ 6,370,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650

￦ 7,741,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

보고서 하이라이트

바이오의약품 및 생물의약품 시장 규모는 2023년 6,213억 1,200만 달러로 평가되었고, 2024년부터 2032년까지 연평균 9.5% 성장할 것으로 예상됩니다.

생물의약품 및 생물의약품 시장 - 시장 역학

바이오의약품 및 생물의약품 분야의 제품 출시 및 승인 급증

바이오의약품 및 생물의약품 분야에서 제품 출시 및 승인률이 눈에 띄게 급증하고 있으며, 이는 업계의 빠른 혁신과 확장을 보여주고 있습니다. 미국 식품의약국(FDA)의 데이터에 따르면 최근 몇 년동안 규제 당국의 승인을 받은 바이오 의약품의 수가 꾸준히 증가하고 있으며, 신약 승인 건수는 매년 사상 최고치를 기록하고 있습니다. 이러한 추세는 획기적인 바이오의약품 및 생물의약품 제품 개발을 통해 미충족 의료 수요를 충족시키고 환자 치료 결과를 개선하려는 업계의 노력을 강조합니다.

바이오의약품 및 생물의약품 시장 - 주요 인사이트

당사의 리서치 애널리스트 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 매년 약 9.5%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

제품 유형별로는 단클론항체가 2023년 가장 큰 시장 점유율을 차지할 것으로 예측됩니다.

용도별로는 2023년에는 치료제가 주요 유형이 될 것으로 예상됩니다.

지역별로는 북미가 2023년 매출을 주도하고 있습니다.

바이오의약품 및 생물의약품 시장 - 세분화 분석 :

바이오의약품 및 생물의약품 세계 시장은 제품 유형, 용도, 치료 분야 및 지역에 따라 세분화됩니다.

시장은 제품 유형에 따라 두 가지 범주로 나뉩니다: 단일 클론 항체는 암 치료 및 자가면역 질환과 같은 치료 용도에 널리 사용됩니다. 나노 의약품은 분자 수준에서 질병을 진단, 치료 및 예방하는 것으로, 약물 전달 및 이미징 응용 분야에서 표적화된 전달 및 효능 향상을 제공합니다.

시장은 용도에 따라 세 가지 범주로 나뉩니다: 질병이나 병을 치료하는 데 이용됩니다. 진단약은 질병이나 상태를 식별하고 진단하는 데 사용됩니다. 연구 개발은 신약 개발 및 약물 개발을 위한 과학 연구 및 실험 연구에 적용됩니다.

바이오의약품 및 생물의약품 시장 - 지리적 통찰력

지리적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다.

북미와 유럽은 선진화된 의료 인프라, 탄탄한 R&D 역량, 유리한 규제 환경을 바탕으로 주요 기업로 자리매김하고 있습니다. 반면, 아시아태평양은 의료비 증가, 만성질환의 확산, 혁신적 치료법에 대한 접근성 확대로 인해 큰 성장 잠재력을 보여주고 있습니다. 라틴아메리카와 중동 및 아프리카 역시 의료 인프라, 의료비 부담 감소, 규제 복잡성 등의 과제는 있지만, 시장 확대의 잠재력을 가지고 있습니다.

바이오의약품 및 생물의약품 시장 - 경쟁 환경:

여러 주요 기업들이 R&D 투자, 인수합병, 전략적 제휴 등의 전략을 통해 패권을 다투고 있습니다. 로슈, 화이자, 존슨앤드존슨과 같은 기업들은 다양한 바이오의약품 포트폴리오와 광범위한 세계 진출로 시장을 선도하고 있습니다. 또한, 암젠, 바이오젠, 길리어드 사이언스 등 혁신적인 생명공학 기업들도 획기적인 치료법과 신약 후보물질로 시장 경쟁에 기여하고 있습니다. 치열한 경쟁 속에서 각 기업은 제품 혁신, 규제 당국의 승인, 시장 확대 노력을 통해 차별화를 꾀하고 있습니다.

개요
- 제품 유형별 부문 점유율 분석
- 단클론항체
  - 백신
  - 재조합 인간 인슐린
  - 인간 성장 호르몬
  - 에리스로포이에틴
  - 인터페론
  - 기타
- 나노 의료
  - 세포 및 유전자 치료
  - 바이오인포매틱스
  - 분자 효소 및 키트

제8장 바이오의약품 및 생물의약품 시장 : 용도별

개요
- 용도별 부문 점유율 분석
- 치료제
- 진단
- 연구개발

제9장 바이오의약품 및 생물의약품 시장 : 치료 분야별

개요
- 치료 분야별 부문 점유율 분석
- 종양학
- 신경학
- 심장병학
- 면역학
- 감염증
- 희귀질환

제10장 바이오의약품 및 생물의약품 시장 : 지역별

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 : 바이오의약품 및 생물의약품 업계

경쟁 대시보드
기업 개요
- Amgen Inc.
- F. Hoffmann-La Roche Ltd
- Johnson &Johnson Services, Inc.
- Pfizer Inc.
- Sanofi
- Eli Lilly and Company
- AbbVie Inc.
- Novo Nordisk A/S
- Bristol-Myers Squibb Company
- NanoString
- QIAGEN
- Affimed GmbH
- GSK plc.
- Merck KgaA
- Teva Pharmaceutical Industries Ltd.
- Others

제12장 애널리스트의 전방위 전망

LSH

영문 목차

영문목차

REPORT HIGHLIGHT

Biopharmaceutical and Biomedicine Market size was valued at USD 621,312 Million in 2023, expanding at a CAGR of 9.5% from 2024 to 2032.

The biopharmaceutical and biomedicine market encompasses the development, production, and commercialization of pharmaceuticals and medical products derived from biological sources. The growing adoption of precision medicine and personalized therapies, advancements in biotechnology such as gene editing and cell therapy, and increased focus on rare diseases and orphan drugs. However, restraints in the biopharmaceutical and biomedicine market include stringent regulatory requirements, high research and development costs, and challenges related to manufacturing and scaling up production. Opportunities abound in emerging markets, expansion into therapeutic areas with unmet medical needs, and strategic collaborations and partnerships for drug discovery and development.

Biopharmaceutical and Biomedicine Market- Market Dynamics

Surging rates of product launches and approvals in the biopharmaceuticals and biomedicines sector

The biopharmaceuticals and biomedicines sector is witnessing a notable surge in rates of product launches and approvals, indicative of the industry's rapid innovation and expansion. According to data from the U.S. Food and Drug Administration (FDA), there has been a steady increase in the number of biopharmaceutical products receiving regulatory approval in recent years, with a record number of new drug approvals reported annually. This trend underscores the industry's commitment to addressing unmet medical needs and improving patient outcomes through the development of groundbreaking biopharmaceutical and biomedicine products.

Biopharmaceutical and Biomedicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2024-2032)

Based on product type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on application segmentation, Therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Biopharmaceutical and Biomedicine Market- Segmentation Analysis:

The Global Biopharmaceutical and Biomedicine Market is segmented based on Product Type, Application, Therapeutic Area, and Region.

The market is divided into two categories based on product type: Monoclonal Antibodies widely used in therapeutic applications such as cancer treatment and autoimmune diseases. Nanomedicine is for diagnosing, treating, and preventing diseases at the molecular level, offering targeted delivery and enhanced efficacy in drug delivery and imaging applications.

The market is divided into three categories based on application: Utilized for treating diseases and medical conditions. Diagnostics are used for identifying and diagnosing diseases or conditions. Research and Development are applied in scientific research and experimental studies for drug discovery and development.

Biopharmaceutical and Biomedicine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe stand as key players, boasting advanced healthcare infrastructure, robust research and development capabilities, and favorable regulatory environments. Meanwhile, the Asia-Pacific region demonstrates significant growth potential, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and expanding access to innovative therapies. Latin America and the Middle East & Africa regions also present opportunities for market expansion, albeit with challenges related to healthcare infrastructure, affordability, and regulatory complexities.

Biopharmaceutical and Biomedicine Market- Competitive Landscape:

Several key players vie for dominance through strategies such as research and development investments, mergers and acquisitions, and strategic partnerships. Companies including Roche, Pfizer, and Johnson & Johnson lead the market with diverse portfolios of biopharmaceutical products and extensive global reach. Additionally, innovative biotechnology firms such as Amgen, Biogen, and Gilead Sciences contribute to market competitiveness with groundbreaking therapies and novel drug candidates. As competition intensifies, companies focus on differentiation through product innovation, regulatory approvals, and market expansion efforts.

Recent Developments:

In May 2022, JSR Life Sciences unveiled a new business division called Similis Bio, aimed at collaborating with biopharmaceutical firms to enhance efficiency and lower costs associated with biosimilar development.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Amgen Inc.

F. Hoffmann-La Roche Ltd

Johnson & Johnson Services, Inc.

Pfizer Inc.

Sanofi

Eli Lilly and Company

AbbVie Inc.

Novo Nordisk A/S

Bristol-Myers Squibb Company

NanoString

QIAGEN

Affimed GmbH

GSK plc.

Merck KgaA

Teva Pharmaceutical Industries Ltd.

Others

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Monoclonal Antibodies
Vaccines
Recombinant Human Insulin
Human Growth Hormone
Erythropoietin
Interferon
Others
Nanomedicine
Cell & Gene Therapy
Bioinformatics
Molecular Enzymes & Kits

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Therapeutics
Diagnostics
Research and Development

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

Oncology
Neurology
Cardiology
Immunology
Infectious Diseases
Rare Diseases

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1.Biopharmaceutical and Biomedicine Market Overview

1.1.Study Scope
1.2.Market Estimation Years

2.Executive Summary

2.1.Market Snippet
- 2.1.1.Biopharmaceutical and Biomedicine Market Snippet by Product Type
- 2.1.2.Biopharmaceutical and Biomedicine Market Snippet by Application
- 2.1.3.Biopharmaceutical and Biomedicine Market Snippet by Therapeutic Area
- 2.1.4.Biopharmaceutical and Biomedicine Market Snippet by Country
- 2.1.5.Biopharmaceutical and Biomedicine Market Snippet by Region
2.2.Competitive Insights

3.Biopharmaceutical and Biomedicine Key Market Trends

3.1.Biopharmaceutical and Biomedicine Market Drivers
- 3.1.1.Impact Analysis of Market Drivers
3.2.Biopharmaceutical and Biomedicine Market Restraints
- 3.2.1.Impact Analysis of Market Restraints
3.3.Biopharmaceutical and Biomedicine Market Opportunities
3.4.Biopharmaceutical and Biomedicine Market Future Trends

4.Biopharmaceutical and Biomedicine Industry Study

4.1.PEST Analysis
4.2.Porter's Five Forces Analysis
4.3.Growth Prospect Mapping
4.4.Regulatory Framework Analysis

5.Biopharmaceutical and Biomedicine Market: COVID-19 Impact Analysis

5.1.Pre-COVID-19 Impact Analysis
5.2.Post-COVID-19 Impact Analysis
- 5.2.1.Top Performing Segments
- 5.2.2.Marginal Growth Segments
- 5.2.3.Top Looser Segments
- 5.2.4.Marginal Loss Segments

6.Biopharmaceutical and Biomedicine Market Landscape

6.1.Biopharmaceutical and Biomedicine Market Share Analysis, 2023
6.2.Breakdown Data, by Key Manufacturer
- 6.2.1.Established Players' Analysis
- 6.2.2.Emerging Players' Analysis

7.Biopharmaceutical and Biomedicine Market - By Product Type

7.1.Overview
- 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2.Monoclonal Antibodies
  - 7.1.2.1.Vaccines
  - 7.1.2.2.Recombinant Human Insulin
  - 7.1.2.3.Human Growth Hormone
  - 7.1.2.4.Erythropoietin
  - 7.1.2.5.Interferon
  - 7.1.2.6.Others
- 7.1.3.Nanomedicine
  - 7.1.3.1.Cell & Gene Therapy
  - 7.1.3.2.Bioinformatics
  - 7.1.3.3.Molecular Enzymes & Kits

8.Biopharmaceutical and Biomedicine Market - By Application

8.1.Overview
- 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2.Therapeutics
- 8.1.3.Diagnostics
- 8.1.4.Research and Development

9.Biopharmaceutical and Biomedicine Market - By Therapeutic Area

9.1.Overview
- 9.1.1.Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
- 9.1.2.Oncology
- 9.1.3.Neurology
- 9.1.4.Cardiology
- 9.1.5.Immunology
- 9.1.6.Infectious Diseases
- 9.1.7.Rare Diseases

10.Biopharmaceutical and Biomedicine Market- By Geography

10.1.Introduction
- 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2.North America
- 10.2.1.Overview
- 10.2.2.Biopharmaceutical and Biomedicine Key Manufacturers in North America
- 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6.North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.2.7.U.S.
  - 10.2.7.1.Overview
  - 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5.U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.2.8.Canada
  - 10.2.8.1.Overview
  - 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5.Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.3.Europe
- 10.3.1.Overview
- 10.3.2.Biopharmaceutical and Biomedicine Key Manufacturers in Europe
- 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6.Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.7.Germany
  - 10.3.7.1.Overview
  - 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5.Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.8.Italy
  - 10.3.8.1.Overview
  - 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5.Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.9.United Kingdom
  - 10.3.9.1.Overview
  - 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5.United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.10.France
  - 10.3.10.1.Overview
  - 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5.France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.11.Russia
  - 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.4.Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.12.Netherlands
  - 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.4.Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.13.Sweden
  - 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.4.Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.14.Poland
  - 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.4.Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.3.15.Rest of Europe
  - 10.3.15.1.Overview
  - 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5.Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.4.Asia Pacific (APAC)
- 10.4.1.Overview
- 10.4.2.Biopharmaceutical and Biomedicine Key Manufacturers in Asia Pacific
- 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6.Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.7.India
  - 10.4.7.1.Overview
  - 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5.India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.8.China
  - 10.4.8.1.Overview
  - 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5.China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.9.Japan
  - 10.4.9.1.Overview
  - 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5.Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.10.South Korea
  - 10.4.10.1.Overview
  - 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5.South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.11.Australia
  - 10.4.11.1.Overview
  - 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5.Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.12.Thailand
  - 10.4.12.1.Overview
  - 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5.Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.13.Indonesia
  - 10.4.13.1.Overview
  - 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5.Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.14.Philippines
  - 10.4.14.1.Overview
  - 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5.Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.4.15.Rest of APAC
  - 10.4.15.1.Overview
  - 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5.Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.5.Latin America
- 10.5.1.Overview
- 10.5.2.Biopharmaceutical and Biomedicine Key Manufacturers in Latin America
- 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6.Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.5.7.Brazil
  - 10.5.7.1.Overview
  - 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5.Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.5.8.Mexico
  - 10.5.8.1.Overview
  - 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5.Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.5.9.Argentina
  - 10.5.9.1.Overview
  - 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5.Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.5.10.Colombia
  - 10.5.10.1.Overview
  - 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5.Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.5.11.Rest of LATAM
  - 10.5.11.1.Overview
  - 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5.Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
10.6.Middle East and Africa
- 10.6.1.Overview
- 10.6.2.Biopharmaceutical and Biomedicine Key Manufacturers in Middle East and Africa
- 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6.Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.7.Saudi Arabia
  - 10.6.7.1.Overview
  - 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5.Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.8.United Arab Emirates
  - 10.6.8.1.Overview
  - 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5.United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.9.Israel
  - 10.6.9.1.Overview
  - 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5.Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.10.Turkey
  - 10.6.10.1.Overview
  - 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5.Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.11.Algeria
  - 10.6.11.1.Overview
  - 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5.Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.12.Egypt
  - 10.6.12.1.Overview
  - 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5.Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
- 10.6.13.Rest of MEA
  - 10.6.13.1.Overview
  - 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5.Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Biopharmaceutical and Biomedicine Industry

11.1.Competitive Dashboard
11.2.Company Profiles
- 11.2.1.Amgen Inc.
- 11.2.2.F. Hoffmann-La Roche Ltd
- 11.2.3.Johnson & Johnson Services, Inc.
- 11.2.4.Pfizer Inc.
- 11.2.5.Sanofi
- 11.2.6.Eli Lilly and Company
- 11.2.7.AbbVie Inc.
- 11.2.8.Novo Nordisk A/S
- 11.2.9.Bristol-Myers Squibb Company
- 11.2.10.NanoString
- 11.2.11.QIAGEN
- 11.2.12.Affimed GmbH
- 11.2.13.GSK plc.
- 11.2.14.Merck KgaA
- 11.2.15.Teva Pharmaceutical Industries Ltd.
- 11.2.16.Others

12.360 Degree Analyst View

13.Appendix

13.1.Research Methodology
13.2.References
13.3.Abbreviations
13.4.Disclaimer
13.5.Contact Us